2020
DOI: 10.1007/s10238-020-00638-z
|View full text |Cite
|
Sign up to set email alerts
|

The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 45 publications
0
8
0
Order By: Relevance
“…Other non‐coding RNAs, like lncRNAs and microRNAs, were reported to be present in exosomes earlier and might be served as new biomarkers in cancer diagnosis. The sensitivity, specificity, and AUC of exosomal lncRNAs for the diagnosis of cancer were 0.83, 0.80, and 0.88, respectively 12 . A meta‐analysis including 1591 patients revealed that the pooled sensitivity, specificity, and AUC of exosomal microRNAs were 0.86, 0.89, and 0.94, respectively 38 .…”
Section: Discussionmentioning
confidence: 99%
“…Other non‐coding RNAs, like lncRNAs and microRNAs, were reported to be present in exosomes earlier and might be served as new biomarkers in cancer diagnosis. The sensitivity, specificity, and AUC of exosomal lncRNAs for the diagnosis of cancer were 0.83, 0.80, and 0.88, respectively 12 . A meta‐analysis including 1591 patients revealed that the pooled sensitivity, specificity, and AUC of exosomal microRNAs were 0.86, 0.89, and 0.94, respectively 38 .…”
Section: Discussionmentioning
confidence: 99%
“…LncRNAs play an important role in the oncogenesis, especially in the development and progression of tumors through the wingless‐type (Wnt), Hedgehog, Notch, and phosphoinositide 3-kinases (PI3Ks)/protein kinase B alpha (AKT)/mammalian target of rapamycin (mTOR) signaling pathways [ 41 ]. Dysregulation of several lncRNAs has been found in various cancer types such as breast, ovarian, cervical, and prostate cancers, suggesting the use of lncRNAs as markers for cancer detection and prognosis, as well as for therapeutic purposes [ 41 , 42 ].…”
Section: Lncrnas and Bmps Signaling Pathwaymentioning
confidence: 99%
“…A meta-analysis by Zhu et al showed that liquid biopsy is the best for the diagnosis of pancreatic cancer, while sEVs higher specificity and sensitivity compared with liquid biopsy methods such as ctDNA and CTC [ 101 ]. In addition, miRNAs [ 102 ] and lncRNAs [ 103 ] carried by sEVs are the most promising biomarkers in the diagnosis of pancreatic cancer. Currently, although the use of sEVs remains largely theoretical, ongoing clinical trials will reveal the potential of sEVs in pancreatic cancer development and therapy.…”
Section: Future Prospects Of Sevs In Pancreatic Cancermentioning
confidence: 99%